Characterization of Carbapenemase-Encoding Genes in CREC During the COVID-19 Era

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) has emerged as a significant nosocomial pathogen, particularly in the context of widespread antibiotic usage during the COVID-19 pandemic. The study by Chen et al. set out to address a critical knowledge gap: how have the characteristics and transmission dynamics of carbapenemase-encoding genes (CEGs) in CREC evolved in tertiary hospitals of Guangdong province, China, during the pandemic period (paper)? Understanding these mechanisms is essential, as CEGs—most notably those encoding metallo-β-lactamases such as blaNDM-1—can confer resistance to last-line antibiotics, severely limiting therapeutic options and complicating infection control.

Key Innovation from the Reference Study

This investigation represents one of the most comprehensive, regionally focused analyses of CEG carriage, localization, and transmissibility in CREC isolates within the pandemic context. By integrating molecular epidemiology with robust experimental assays, the study highlights the predominance and dual localization (plasmid and chromosomal) of blaNDM-1, quantifies gene transfer rates, and identifies the prevalence of mobile genetic elements facilitating CEG dissemination. The research uniquely correlates these findings with demographic and clinical patterns, illuminating risk factors for CEG-positive CREC infections (paper).

Methods and Experimental Design Insights

The study analyzed 54 non-duplicate CREC strains collected from eight teaching hospitals in Guangdong province between December 2022 and June 2024. The methodology combined:

• Variable temperature SDS plasmid elimination to distinguish chromosomal versus plasmid-borne CEGs.
• PCR amplification for detection and categorization of blaNDM-1, blaIMP, and blaKPC-2 genes.
• Broth microdilution for antimicrobial susceptibility profiling.
• Plasmid conjugation assays to quantify horizontal gene transfer capacity.
• ERIC-PCR and NTSYS clustering for strain genotyping and epidemiological mapping.
• Mobile genetic element identification to assess the presence and types of elements associated with CEGs.

These approaches enabled the precise mapping of resistance determinants and the investigation of their transmission mechanisms.

Protocol Parameters

• plasmid selection assay | 25–170 μg/mL chloramphenicol | E. coli, Enterobacteriaceae | Stringent (25 μg/mL) vs. relaxed (170 μg/mL) plasmids enable effective selection | product_spec
• protein synthesis inhibition | ≥16.16 mg/mL in DMSO | in vitro bacterial cultures | Ensures complete inhibition of 50S ribosomal subunit and translation | product_spec
• plasmid elimination (variable temperature SDS) | protocol-dependent | Enterobacteriaceae | Differentiates chromosomal from plasmid-encoded resistance | paper
• conjugation frequency measurement | PCR confirmation post-mating | Enterobacteriaceae | Assesses horizontal transferability of resistance genes | paper

Core Findings and Why They Matter

The study revealed several important points:

• High prevalence of CEGs: 85.19% (46/54) of CREC isolates carried at least one carbapenemase-encoding gene (paper).
• blaNDM-1 predominance: 33.33% (18/54) harbored blaNDM-1 on both chromosome and plasmid, 46.30% (25/54) only on plasmid, and 1.85% (1/54) had both blaNDM-1 and blaKPC-2 on plasmid. A smaller fraction (3.70%, 2/54) carried only blaIMP on plasmid.
• Plasmid-mediated transfer: Plasmid conjugation experiments demonstrated a 95.65% (44/46) success rate in CEG transfer, with blaNDM-1 and blaIMP being highly mobile (95.45% and 100% transfer rates, respectively), while blaKPC-2 was not transferable under the tested conditions (paper).
• Antimicrobial resistance profiles: Strains positive for CEGs exhibited significantly higher resistance rates to multiple antibiotics, including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, compared to CEG-negative strains (P<0.05) (paper).
• Mobile genetic elements: Six types were identified, with ISEcp1 being the most prevalent (87.04%, 47/54). CREC strains often carried multiple elements simultaneously, facilitating gene spread.
• Epidemiological risk factors: CEG-positive CREC strains were more frequently detected in male patients (64.81%), elderly individuals (72.22%), respiratory medicine departments (20.37%), and sputum samples (33.33%) (paper).

These findings underscore the urgent need for molecular surveillance and targeted infection control, especially given the high mobility and clinical impact of plasmid-borne resistance determinants.

Comparison with Existing Internal Articles

Internal resources, such as "Transmission and Genetics of Carbapenem Resistance in CREC During COVID-19" (source), echo the reference study’s emphasis on the central role of plasmid-borne blaNDM-1 and the necessity of monitoring resistance gene mobility. Further, articles like "Chloramphenicol: Precision Antibiotic for Molecular Biology" (source) and "Chloramphenicol: Mechanistic Antibiotic for Molecular Bio..." (source) provide methodological context for employing antibiotics such as chloramphenicol in plasmid selection assays to study gene transfer and resistance mechanisms. The reference study diverges by focusing on real-world clinical isolates and transmission dynamics during a pandemic, while internal articles often concentrate on laboratory workflows and molecular tools. Together, these resources bridge the translational gap between surveillance and experimental research on antimicrobial resistance.

Limitations and Transferability

While comprehensive, the study is geographically limited to Guangdong province and covers a defined pandemic timeframe. The sample size (54 isolates) constrains broader generalizability. Additionally, gene transfer dynamics may vary under different environmental or clinical pressures. Nonetheless, the demonstration of high plasmid conjugation rates and multidrug resistance phenotypes in CREC is likely representative of broader trends in nosocomial pathogens, particularly where antibiotic selection pressure is high (paper). Methodologies such as plasmid elimination, conjugation assays, and resistance profiling are readily transferable to other Enterobacteriaceae, facilitating parallel investigations in different regions or under varying epidemiological circumstances (workflow_recommendation).

Research Support Resources

For researchers aiming to study gene transfer, resistance mechanisms, or perform plasmid selection assays, high-purity antibiotics such as Chloramphenicol (SKU: A2512) are widely used for their robust inhibition of bacterial protein synthesis and compatibility with molecular biology protocols (product_spec). APExBIO’s chloramphenicol is validated for use in stringent plasmid selection workflows and supports reproducible research in antimicrobial resistance studies. For detailed parameters and best practices, consult established protocols and product documentation.